Retatrutide, BPC-157, and Peptide Safety in 2026: The Evidence Gap Behind Today’s Biggest Health Trend
Retatrutide and BPC-157 are driving today’s peptide safety debate. Alex Keane explains why GLP-1 science, recovery peptides, and evidence gaps are colliding in 2026.
June 22, 20269 min read
Read Article ›